QR-koodi

The Effects of Sodium-Glucose Cotransporter 2-Inhibitors on Steatosis and Fibrosis in Patients with Non-Alcoholic Fatty Liver Disease or Steatohepatitis and Type 2 Diabetes: A Systematic Review of Randomized Controlled Trials

Type 2 Diabetes Mellitus (T2DM) and non-alcoholic fatty liver disease (NAFLD) are part of metabolic syndrome and share multiple causal associations. Both conditions have an alarmingly increasing incidence and lead to multiple complications, which have an impact on a variety of organs and systems, su...

Täydet tiedot

Tallennettuna:
Päätekijät: Ioana-Cristina Bica, Roxana Adriana Stoica, Teodor Salmen, Andrej Janež, Špela Volčanšek, Djordje Popovic, Emir Muzurovic, Manfredi Rizzo, Anca Pantea Stoian
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: MDPI AG 2023-06-01
Sarja:Medicina
Aiheet:
sodium-glucose cotransporter 2-inhibitors
steatosis
fibrosis
non-alcoholic fatty liver disease
non-alcoholic steatohepatitis
diabetes
Linkit:https://www.mdpi.com/1648-9144/59/6/1136
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia